B3 thymomas and thymic carcinomas (TCs) displayed higher p62 expression (<i>p</i> = 0.019), while LC3b expression was marginally higher in non-B3/TC TETs (<i>p</i> = 0.098). This evidence concerns the gene MAP1LC3B and thymic carcinoma.